Progenics Pharmaceuticals, Inc. (Nasdaq: PGNX) announced today that it is offering to sell, subject to market and other conditions, shares ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE